BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 29.90
+1.80 (6.41%)
At close: Apr 21, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 169.59 million as of April 22, 2026. Its market cap has decreased by -16.56% in one year.
Market Cap
169.59M
Enterprise Value
108.82M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.90
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 169.59M, a decrease of -18.43%. That is a compound annual growth rate of -15.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 174.86M | 22.54% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 934.10M |
| Basilea Pharmaceutica AG | 689.56M |
| Newron Pharmaceuticals | 342.05M |
| Santhera Pharmaceuticals Holding AG | 245.39M |
| Xlife Sciences AG | 132.08M |
| Molecular Partners AG | 122.34M |
| EvoNext Holdings | 6.16M |
| Addex Therapeutics | 5.13M |